These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27921359)

  • 21. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xanthohumol Restores Hepatic Glucolipid Metabolism Balance in Type 1 Diabetic Wistar Rats.
    Lima-Fontes M; Costa R; Rodrigues I; Soares R
    J Agric Food Chem; 2017 Aug; 65(34):7433-7439. PubMed ID: 28745504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
    Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
    Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development.
    Yoshiji H; Noguchi R; Kuriyama S; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Uemura M; Fukui H
    Oncol Rep; 2005 May; 13(5):853-7. PubMed ID: 15809749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
    Ganta VC; Choi M; Kutateladze A; Annex BH
    Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent inhibition of VEGFR-2 activation by tight binding of green tea epigallocatechin gallate and apple procyanidins to VEGF: relevance to angiogenesis.
    Moyle CW; Cerezo AB; Winterbone MS; Hollands WJ; Alexeev Y; Needs PW; Kroon PA
    Mol Nutr Food Res; 2015 Mar; 59(3):401-12. PubMed ID: 25546248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multiscale computational model predicts distribution of anti-angiogenic isoform VEGF
    Chu LH; Ganta VC; Choi MH; Chen G; Finley SD; Annex BH; Popel AS
    Sci Rep; 2016 Nov; 6():37030. PubMed ID: 27853189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Date syrup-derived polyphenols attenuate angiogenic responses and exhibits anti-inflammatory activity mediated by vascular endothelial growth factor and cyclooxygenase-2 expression in endothelial cells.
    Taleb H; Morris RK; Withycombe CE; Maddocks SE; Kanekanian AD
    Nutr Res; 2016 Jul; 36(7):636-47. PubMed ID: 27333954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis.
    Anisimov A; Tvorogov D; Alitalo A; Leppänen VM; An Y; Han EC; Orsenigo F; Gaál EI; Holopainen T; Koh YJ; Tammela T; Korpisalo P; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Dejana E; Koh GY; Choi C; Saharinen P; Alitalo K
    Circulation; 2013 Jan; 127(4):424-34. PubMed ID: 23357661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular structure-function relationship of dietary polyphenols for inhibiting VEGF-induced VEGFR-2 activity.
    Cerezo AB; Winterbone MS; Moyle CW; Needs PW; Kroon PA
    Mol Nutr Food Res; 2015 Nov; 59(11):2119-31. PubMed ID: 26250940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway.
    Liu W; Xu J; Wang M; Wang Q; Bi Y; Han M
    Int J Oncol; 2011 Nov; 39(5):1213-20. PubMed ID: 21785819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A computational analysis of pro-angiogenic therapies for peripheral artery disease.
    Clegg LE; Mac Gabhann F
    Integr Biol (Camb); 2018 Jan; 10(1):18-33. PubMed ID: 29327758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF-kappaB and Akt as targets.
    Albini A; Dell'Eva R; Vené R; Ferrari N; Buhler DR; Noonan DM; Fassina G
    FASEB J; 2006 Mar; 20(3):527-9. PubMed ID: 16403733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.